Thus, the combined treatment of a drug leading to a depletion of cyclin D1 and a DNA damage inducer, such as irradiation, could be an interesting potential therapy to target cancers with a high rate of DNA repair, especially in the case of chemo- and radio-resistant tumors. Here, CCND1 is linked to cancer.